NNDM compared with AUPH: revenue, margins and what each company keeps, and the suppliers and customers both name

NNDMNano Dimension Ltd.

Mkt capRevenueRevenue

AUPHAurinia Pharmaceuticals Inc.

Mkt capRevenueRevenue

Compare

NNDMNano Dimension Ltd.

AUPHAurinia Pharmaceuticals Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only NNDM 0

None

Shared 0

No disclosed counterparties: NNDM.

Only AUPH 3

—Catalent Pharma Solutionsunlistedsupplier

—Lonzaunlistedsupplier

—Otsuka Pharmaceuticalunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

NNDMNano Dimension Ltd.

1.34▲+6.37%

Mkt cap$278.3MRevenue$32MQ3 FY26Revenue—

AUPHAurinia Pharmaceuticals Inc.

16.26▲+0.33%

Regular sessionNov 6 '26

Mkt cap$2.2BRevenue$84MQ3 FY26Revenue$283MFY25

Compare

Regular sessionNov 6 '26

NNDMNano Dimension Ltd.

AUPHAurinia Pharmaceuticals Inc.

1.34▲+6.37%

Price

16.26▲+0.33%

$278.3M

Mkt cap

$2.2B

Q3 FY26$32M

Revenue

$84MQ3 FY26

—

Revenue

$283MFY25

NNDM1.34▲+6.37%vsAUPH16.26▲+0.33%Regular sessionNov 6 '26